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Linkage Analysis Identiﬁes a Novel Locus for Restless Legs
Syndrome on Chromosome 2q in a South Tyrolean
Population Isolate
Irene Pichler, Fabio Marroni, Claudia Beu Volpato, James F. Gusella, Christine Klein, Giorgio Casari,
Alessandro De Grandi, and Peter P. Pramstaller
Restless legs syndrome (RLS) is a common neurological condition with three loci (12q, 14q, and 9p) described so far,
although none of these genes has yet been identiﬁed. We report a genomewide linkage scan of patients with RLS (np
) assessed in a population isolate ( ) of South Tyrol (Italy). Using both nonparametric and parametric analyses,37 np 530
we initially obtained suggestive evidence of a novel locus on chromosome 2q, with nominal evidence of linkage on
chromosomes 5p and 17p. Follow-up genotyping yielded signiﬁcant evidence of linkage (nonparametric LOD score 5.5,
; heterogeneity LOD score 5.1; ) on chromosome 2q. Three families (S01, S05, and S016) were shownP  .0000033 ap 1.0
to descend from a common founder couple. A disease haplotype shared between family S01 and family S05 deﬁnes a
candidate region of 8.2 cM; in addition, the single affected individual in family S016 shares three linked alleles at
neighboring markers, which suggests a reduced candidate interval of only 1.6 cM. Two-point linkage analysis in this 10-
generation pedigree provided signiﬁcant evidence of a novel RLS locus in this region (LOD score 4.1). These ﬁndings
reemphasize the genetic heterogeneity of the disorder and strongly support the identiﬁcation of a novel locus for RLS
on chromosome 2q.
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Restless legs syndrome (RLS [MIM 102300]) is a common
and frequently underdiagnosed neurological disorder. Es-
timated prevalence rates vary widely, from 2% to 15% of
the general population.1,2 RLS can be diagnosed by the
clinical presence of four essential criteria developed by the
International Restless Legs Syndrome Study Group3 and
revised in a National Institutes of Health consensus state-
ment4: (1) an urge to move the legs, usually accompanied
by uncomfortable sensations (paresthesias, dysesthesias),
(2) occurrence of symptoms primarily while at rest, (3)
partial or total relief with movement, and (4) worsening
of symptoms in the evening or night. RLS is generally
classiﬁed into idiopathic and symptomatic forms. In idio-
pathic RLS, which includes both sporadic and familial
cases, results of physical and neurological examinations
are normal. Symptomatic (secondary) forms can be caused
by many conditions, such as polyneuropathy, iron deﬁ-
ciency, anemia, kidney disease, or thyroid dysfunction.5
A substantial genetic contribution to idiopathic RLS has
been consistently recognized from population and family
studies. A family history of RLS was described in 40%–
90% of patients,6 and the high concordance rate of 83.3%
between identical twins was reported.7 In a set of multi-
plex families from North America, the heritability of RLS
was estimated to be 0.60.8 Most reports of familial cases
have suggested autosomal dominant transmission,9 al-
though broad intrafamilial phenotypic expressivity, with
a variable age at onset and disease course, has been re-
ported.10 To date, linkage studies have identiﬁed three loci
on chromosomes—12q,11 14q,12 and 9p8—in RLS-affected
families from different populations. However, no disease-
causing gene has yet been identiﬁed. These molecular
ﬁndings, together with the reported variable expressivity
of the phenotype, suggest substantial genetic and clinical
heterogeneity of RLS.
One way to reduce the genetic complexity, and poten-
tially also the environmental heterogeneity, is the use of
isolated populations. Here, we report a genomewide link-
age analysis of patients with RLS collected from one small
village that has conserved a high degree of isolation in
the western Alps of South Tyrol (Italy). It reveals increased
background linkage disequilibrium (LD) due to the pecu-
liar demographic history that has led to genetic drift and
founder effects.13 The village originates from an old set-
tlement, has few founders, and experienced slow expan-
sion over time. Apart from these demographic character-
istics relating to the population history and therefore
associated with the genetic background, historical docu-
ments allowed the reconstruction of extended pedigrees
as far back as the 17th century.14 The study is part of a
larger ongoing genomic research program (GenNova) in-
vestigating the South Tyrolean population.
The RLS phenotype was clinically assessed in two steps.
First, a detailed questionnaire-based interview and a med-
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Table 1. Clinical Features of RLS in the 16 Patients of Families S01, S05, and S016
Family
and
Patient Sex
Age
(years)
Severity
(IRLS/JHRLSS)a Awakenings
Involvement
of Upper
Limbs
Lateralization
of Symptoms Course
Haplotype
Status
(c2q/c5p)b
At
Study
At
Onset
S01:
VIII-1 F 70 12 32/2   Left Progressive /
VIII-2 F 76 12 31/3    Progressive /
VIII-5 M 79 60 NA   Left Stable /
VIII-7 M 68 30 10/1    Remission /
VIII-11 M 63 50 11/2   Right Stable /
IX-14 M 43 20 18/2    Progressive /
IX-16 M 39 15 15/2   Right Remission /
IX-17 F 51 41 20/2    Stable /
IX-19 F 34 29 10/1   Left Progressive /
IX-22 M 36 31 7/2    Stable /
IX-24 M 27 25 7/2    Stable /
X-27 F 14 13 6/1    Stable /
S05:
VIII-1 M 64 49 13/1    Remission /
VIII-2 F 59 52 12/2    Stable /
VIII-3 M 63 58 NA    Stable /
S016:
IX-3 M 39 35 8/1    Stable /
a NA p not assessed.
b Individuals sharing the haplotypes on chromosomes 2q and 5p are identiﬁed with /; those sharing the haplotype only on
chromosome 2q are identiﬁed with /.
ical screening exam of 530 voluntary study participants
were performed. The questionnaire included the fourmin-
imal criteria for RLS.3 A blood sample was taken for DNA
extraction and routine clinical chemistry analysis. In the
second step, subjects presumed to have RLS were reexam-
ined by a movement-disorder specialist. A standardized
neurological examination was performed, and a detailed
interview covered age at onset of symptoms, family his-
tory, localization of symptoms, lateralization, and sleep
problems. The severity of symptoms was rated using both
the International Restless Legs Syndrome Rating Scale
(IRLS)15 and the Johns Hopkins Restless Legs Severity Scale
(JHRLSS).16 The ﬁnal diagnosis of RLS was made accord-
ing to currently accepted diagnostic criteria.4 Secondary
causes of RLS were determined by electrophysiology and
biochemical tests, including laboratory parameters for iron
metabolism; renal, hepatic and endocrine function; and
diabetes. None of the subjects reported the use of medi-
cation known to affect sleep or sensory or motor func-
tions. Thirty-seven patients with idiopathic RLS whose an-
cestry was from this village were identiﬁed; three patients
(members of families S01, S02, and S03) were designated
as having uncertain status. Nine individuals with symp-
toms associated with secondary RLS were excluded from
the present study. Twelve affected individuals clustered in
one large and extended family (S01), and 17 other families
consisted of 1–5 affectedmembers each. Six of the families
(S01, S02, S03, S05, S06, and S08) were informative for
linkage; the remaining 12 were subsequently included for
haplotype analysis. Of the 18 families, 61 clinically un-
affected members were available for the study. Disease
status of 31 unaffected individuals was set as “unknown,”
because they participated only in the ﬁrst step of the phe-
notype assessment. Of 14 fully assessed healthy members
of S01, one was set as “unknown,” because his age was
lower than the mean age at onset plus 1 SD, as obtained
from the sample of affected individuals in this family.
Study participants gave written informed consent. The
study was approved by the local ethics committee.
We performed a 4-cM genomewide linkage scan onDNA
from all 530 study participants, using 1,000 microsatellite
markers (i.e., STRs) genotyped at deCODE Genetics. The
data were analyzed by multipoint model-free and para-
metric linkage analyses with use of the software GENE-
HUNTER 2.1.17 For the model-free analysis, the NPL score
was calculated using the Sall statistic to estimate the allele
sharing among all affected individuals in the pedigrees.
Because of program memory constraints, 3 affected and
13 unaffected individuals of the largest family (S01) were
dropped from the analysis. The parametric analysis was
performed under the assumption of an autosomal domi-
nant model, which allowed for locus heterogeneity. The
disease-allele frequency was set at 0.001, and penetrances
were set at 0.7, 0.7, and 0.01 for homozygotes, heterozy-
gotes, and noncarriers, respectively. Marker-allele frequen-
cies were estimated on the basis of the 530 study partici-
pants, and recombination rates formales and femaleswere
assumed to be equal.
The results of the genomewide multipoint nonpara-
metric and parametric analyses are presented in ﬁgure 1.
The highest signal among the 22 scanned autosomes was
observed for marker D2S117, with an NPL score of 3.79
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Figure 1. Results of the genomewide scan for each chromosome. The black curve represents NPL scores, the gray curve represents
HLOD scores, and the dotted curve represents STR marker informativity. Genetic distances are based on the deCODE Genetic map.
( ) and a LOD1 interval of 18.47 cM. The high-Pp .0042
est heterogeneity LOD (HLOD) score (2.88) was detected
between markers D2S311 and D2S116 ( ). Despiteap 1.0
the fact that linkage analysis in the presence of hetero-
geneity is robust and powerful for complex diseases, the
estimate of the proportion of linked families, a, is not
accurate in this circumstance.18–20 The largest multigener-
ational family (S01) contributed the bulk of the score for
the linkage peak on chromosome 2q (LOD score of 2.34
at marker D2S117 and corresponding NPL score of 12.5
[ ]). In addition, two other regions of the genomePp .0019
showed nominal evidence of linkage to RLS in the para-
metric multipoint analysis: D5S2848 (HLOD 1.2; ap
) and D17S804 (HLOD 1.0; ).0.43 ap 1.0
To ﬁne map the chromosome 2 candidate region, we
chose a set of 11 additional microsatellite markers
(D2S2392, D2S2289, D2S325, D2S2242, D2S2208,D2S154,
D2S2178, D2S2274, D2S1369, D2S157, and D2S371) from
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the University of California–Santa Cruz (UCSC) Genome
Browser 2004 human genome assembly (UCSC Genome
Bioinformatics). Marker order was based on the physical
map, and genetic distances were based on the sex-averaged
Marshﬁeld genetic map (Center for Medical Genetics Web
site) (ﬁg. 2). We estimated allele frequencies for these
markers from 88 unrelated (during at least the last 3 gen-
erations) individuals of the same village. We genotyped
these markers in 101 individuals from the 18 RLS-affected
families, using a 3100 Sequencer (Applied Biosystems),
and we assigned genotypes using Genemapper version 3.7
software.
For the detailed mapping of the chromosome 2 candi-
date region, we calculated multipoint model-free and para-
metric LOD scores using SIMWALK2,21,22 which allowed
the inclusion of all individuals of S01. A two-point analysis
was performed using the MLINK program (LINKAGE soft-
ware package).23 The same parameters as in the genome-
wide multipoint analysis were used. The SIMWALK2 anal-
ysis (ﬁg. 3) provided strong evidence of a candidate region
between markers D2S311 and D2S317 (11.7 cM), with a
peak NPL score of 5.5 ( ) and a peak HLOD6P 3.33# 10
score of 5.1 at markers D2S325, D2S1369, and D2S157.
These data, which exceed the genomewide signiﬁcance
level deﬁned by Lander and Kruglyak (LOD 3.6; Pp
),24 indicate the presence of an RLS locus in this.000022
region of chromosome 2q.
We next used genotype data for 20 markers on chromo-
some 2q to examine the pattern of haplotype transmission
for all individuals in the 18 families, in an attempt to
identify haplotype sharing among the 37 idiopathic RLS
cases. We found that a common 7-marker haplotype (11-
6-5-8-8-6-5) in the chromosome 2q33 region is shared
identical by descent by all 15 affected members of fami-
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Figure 2. Ten-generation genealogy of the 16 affected individuals of families S01, S05, and S016 and 2q locus haplotypes. Patients
with idiopathic RLS are indicated by blackened symbols; one individual of family S01 with uncertain disease status is indicated by a
symbol with the bottom right corner blackened; RLS suspected by family history is indicated by a dot; examined individuals are denoted
by a bar. Disease status of individuals indicated with a question mark was set as “unknown” for one healthy member of family S01
because his age was lower than the mean age at onset plus 1 SD in this family and was set as “unknown” for four unaffected members
of families S05 and S016 because they participated only in the ﬁrst phase of the phenotype assessment. For computational reasons,
one consanguinity loop had to be broken in the linkage analysis. The arrow depicts the common founder couple. The disease haplotype
is denoted by the blackened vertical bar; the normal haplotype is marked by an unblackened vertical bar. The inset shows marker map
positions and allele frequencies (freq).
lies S01 and S05 (ﬁg. 2). Obligate recombination events
deﬁned a candidate region of 8.2 cM between markers
D2S311 and D2S2208. Notably, the single affected indi-
vidual of family S016 shares the alleles of the disease-chro-
mosome haplotype for only the three distal markers (8-6-
5) (ﬁg. 2). From genealogical studies, we found that fam-
ilies S01, S05, and S016 descended from a common foun-
der couple 10 generations ago (ﬁg. 2). Two-point linkage
analysis of this large genealogy resulted in a maximum
LOD score of 4.1 at at marker D2S2242. The re-vp 0.0
maining 15 families do not descend from a common an-
cestor; in those families, no common haplotype was ob-
served, and the maximum LOD score we obtained was 0.4
in S06.
The three families S01, S05, and S016 also share a com-
mon haplotype for the chromosome 5p region, with the
exception of three affected members of S01 (VIII-7, VIII-
11, and IX-22), but not for the chromosome 17p region.
Proximal and distal recombinants allowed us to deﬁne the
common genomic region as spanning 11.8 cM (between
markers D5S1954 and D5S2848), although the potential
signiﬁcance of this region is unclear.
Clinical data from all 16 affected members of families
S01, S05, and S016, together with the haplotype status on
chromosome 2q33 and chromosome 5p15-p14, are re-
ported in table 1.
We performed our model-based analyses with the as-
sumption of autosomal dominant inheritance with a re-
duced penetrance of 70%. Formal segregation analysis in
a large set of families has argued for a single autosomal
dominant major gene with a multifactorial component in
families with early disease onset (i.e., onset age of !30
years).25 The reported penetrance value varies from full
penetrance26 to 70% for individuals showing only periodic
leg movements during sleep but who are otherwise with-
out RLS symptoms.27 Additionally, in children and mildly
affected individuals with intermittent symptoms, it can
be difﬁcult to recognize the RLS phenotype. To overcome
this possible drawback, we opted for a reduced penetrance
in our linkage analysis. However, reanalysis of our data
with different model parameters, such as increasing the
estimates of penetrance, did not substantially change the
results (e.g., two-point LOD score of 3.3 with 0.9 pene-
trance and 0.01 phenocopies). Similarly, an affected-only
analysis yielded a two-point LOD score of 3.4.
Three other loci have been reported elsewhere for RLS.8,
11,12 Linkage to the chromosome 12q and chromosome14q
loci was recently replicated.28–30 On the other hand, link-
age to chromosome 12q could be replicated neither in two
South Tyrolean families31 nor in two northern Italian fam-
ilies.32 Furthermore, when the same village investigated in
the present report was studied, no evidence of linkage of
RLS was found14 to the three RLS loci described else-
where.8,11,12 These data, together with the substantial var-
iability of symptoms, suggest that RLS may have a poly-
genic basis, with contributions of major genes, modiﬁer
genes, and complex interactions of genes and environ-
ment. In geographically or culturally isolated populations
that descended from a small number of founders, a more
restricted number of susceptibility loci and disease alleles
at each locus can be reasonably expected. In fact, the RLS
locus on 12q was identiﬁed in the French Canadian pop-
ulation, for which a founder effect has been described.11
Recently, it was shown that 31.6% of the total number of
families identiﬁed in the French Canadian population
were linked to the chromosome 12q locus.28
LD and historical data from the South Tyrol region and
the small isolated village suggest that individuals may
share a small number of disease alleles.13 The shared dis-
ease haplotype in related families S01 and S05 effectively
narrows the candidate region to 8.2 cM. Using the pro-
gram PHASE,33 which has been shown to provide accurate
estimates of haplotype frequencies from population data,34
we estimated haplotype frequencies from 88 unrelated in-
dividuals in the village. The extended shared haplotype
from families S01 and S05 was present in only 0.93% of
the control individuals, which strongly indicates that its
shared presence in the affected individuals points to the
presence of an RLS disease allele. By contrast, the popu-
lation frequency of the 3-marker haplotype identiﬁed in
the distantly related S016 was 7%, which makes reliance
on this single individual for deﬁnition of a reduced can-
didate region of 1.6 cM more risky. In the 1.6-cM region,
there are currently 11 annotated genes, of which 3 are pre-
dicted genes with unknown function. Among some plau-
sible candidate genes, we recognized (1) CPO with carbox-
ypeptidase activity, (2) CREB1, which encodes a cAMP-re-
sponsive element-binding protein, and (3) KLF7, Kruppel-
like factor 7, with transcription factor activity. The larger
8.2-cM interval contains 1100 annotated genes. The hap-
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Figure 3. HLOD scores and log(P value) of NPL scores for markers in the 2q region after ﬁne mapping. The black line indicates the
log(P value) of NPL scores, and the gray line indicates the HLOD score. Marker D2S311* is at the same position as marker D2S2392,
marker D2S2321* shares the same position as markers D2S2242 and D2S2208, and marker D2S1369* is close to markers D2S154, D2S2178,
D2S2274, and D2S157; thus, these additional markers are not represented on the graph.
lotype frequency of the chromosome 5 region was esti-
mated to be 23%, suggesting that this interval does not play
a major role in the etiology of RLS in our population.
In summary, our linkage data encompassing 37 idio-
pathic RLS cases from this isolated village and the hap-
lotype-sharing data of patients of three families provide
strong evidence for the identiﬁcation of a new major sus-
ceptibility locus for RLS at 2q33 in a South Tyrolean pop-
ulation isolate. The novel locus provides further evidence
that RLS is a genetically highly heterogeneous disorder. In
addition, it can be expected that the identiﬁcation of the
underlying gene defect at 2q33 will contribute to our cur-
rent understanding of the underlying biological mecha-
nisms of RLS.
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